| 0–14 days | 15–30 days | 31–90 days | >90 days |
P* | |
---|
pAEa
| 60%(32/53) | 70%(37/53) | 74%(39/53) | 81%(43/53) | 0.123 | |
dALEb
| 10%(2/20) | 15%(3/20) | 15%(3/20) | 35%(7/20) | 0.184 | |
prNMDAREc
| 16%(5/31) | 42%(13/31) | 87%(27/31) | 100%(31/31) | 0.000 | |
-
*
P < 0.05 is significant
-
asensitivity of possible autoimmune encephalitis assessed by pAE(+)/all the autoimmune encephalitis cases
-
bsensitivity of definite autoimmune limbic encephalitis assessed by dALE(+)/all the limbic encephalitis cases
-
csensitivity of probable anti-NMDA receptor encephalitis assessed by prNMDARE(+)/all the anti-NMDAR encephalitis cases